Cite
HARVARD Citation
Coombs, J. et al. (2010). Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690, 550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases. 69 (2), pp. 413-416. [Online].